The review presents. as the classical data on the mechanism of action of metabolic cytoprotector trimetazidine in acute ischemia/reperfusion injury associated with a partial inhibition of the oxidation of long chain fatty acids and increased metabolism of pyruvate. as well as new concepts of reducing the level of oxidative stress. reduction of cardiomyocyte apoptosis. https://www.roneverhart.com/Audio-Savage/